Analyst firms · Raymond James · NGM

Raymond James NGM price target and rating history

NGM Biopharmaceuticals Inc. (NGM) · Health Care

Raymond James rates NGM Biopharmaceuticals Inc. (NGM) Mkt Perform with a $4 price target, as of its latest action on Mar 12, 2024. It has published 5 rating actions on NGM since August 2021, including 1 upgrade and 2 downgrades.

Current rating
Mkt Perform
Price target
$4
Median target, all firms
Too few
Actions on NGM
5

Raymond James price target on NGM

$42$23$420222023202420252026
Raymond James price target on NGM, each point a stated target, August 2021 to October 2022.

Every Raymond James rating on NGM

Questions about Raymond James and NGM

What is Raymond James's price target for NGM?
Raymond James's latest stated price target for NGM Biopharmaceuticals Inc. (NGM) is $4, from its action on Oct 18, 2022.
What is Raymond James's rating on NGM?
Raymond James rates NGM Mkt Perform, a neutral rating, as of Mar 12, 2024.
When did Raymond James last change its view on NGM?
On Mar 12, 2024, Raymond James downgrades to Mkt Perform from Outperform.

All Raymond James ratingsNGM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.